Metastasis is driven by sequential elevation of H-ras and Smad2 levels
- PMID: 12105419
- DOI: 10.1038/ncb807
Metastasis is driven by sequential elevation of H-ras and Smad2 levels
Abstract
Metastasis is a multistep process that involves local tumour invasion followed by dissemination to, and re-establishment at, distant sites. Here we show that during multistage tumorigenesis, discrete expression thresholds of activated Smad2 and H-ras are sequentially surpassed, driving tumour progression through distinct phases from a differentiated squamous carcinoma to a motile invasive stage, followed by an overt change from epithelial to mesenchymal cell type, finally culminating in metastatic tumour spread. Smad2 activation alone induces migration of tumour cells. Elevated H-ras levels, however, are required for nuclear accumulation of Smad2, both of which are essential for the epithelial mesenchymal transition (EMT). Having undergone EMT, fibroblastoid carcinoma cells with elevated levels of activated Smad2, gain the capability to spread to a wide variety of tissues by a further increase in Smad2 expression. These findings have far-reaching implications for the prevention of tumour growth, invasion and metastasis.
Similar articles
-
Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.Cancer Res. 2004 Jul 1;64(13):4523-30. doi: 10.1158/0008-5472.CAN-04-0030. Cancer Res. 2004. PMID: 15231662
-
Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.Oncogene. 2003 Jul 10;22(28):4314-32. doi: 10.1038/sj.onc.1206478. Oncogene. 2003. PMID: 12853969
-
Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.Cancer Res. 2003 Nov 15;63(22):7760-8. Cancer Res. 2003. PMID: 14633701
-
[Epithelial-mesenchymal transition in cancer progression].Postepy Biochem. 2009;55(2):121-8. Postepy Biochem. 2009. PMID: 19824467 Review. Polish.
-
Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters.Lancet Oncol. 2004 Apr;5(4):254-8. doi: 10.1016/S1470-2045(04)01431-7. Lancet Oncol. 2004. PMID: 15050959 Review.
Cited by
-
Investigating the impact of SMAD2 and SMAD4 downregulation in colorectal cancer and their correlation with immune markers, prognosis, and drug resistance and sensitivity.Mol Biol Rep. 2024 Jul 22;51(1):831. doi: 10.1007/s11033-024-09697-x. Mol Biol Rep. 2024. PMID: 39037563
-
From shape-shifting embryonic cells to oncology: The fascinating history of epithelial mesenchymal transition.Semin Cancer Biol. 2023 Nov;96:100-114. doi: 10.1016/j.semcancer.2023.10.003. Epub 2023 Oct 16. Semin Cancer Biol. 2023. PMID: 37852342 Free PMC article. Review.
-
TGF-β signaling in health and disease.Cell. 2023 Sep 14;186(19):4007-4037. doi: 10.1016/j.cell.2023.07.036. Cell. 2023. PMID: 37714133 Free PMC article. Review.
-
Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer.Cancer Res. 2023 Apr 4;83(7):1031-1047. doi: 10.1158/0008-5472.CAN-22-2586. Cancer Res. 2023. PMID: 36753744 Free PMC article.
-
Clinical and Biological Significances of FBLN5 in Gastric Cancer.Cancers (Basel). 2023 Jan 16;15(2):553. doi: 10.3390/cancers15020553. Cancers (Basel). 2023. PMID: 36672502 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous